"MSK Bergen offers the same expert cancer care patients expect from Memorial Sloan Kettering, just closer to home. Patients are able to receive much of their treatment — including chemotherapy, immunotherapy, and radiation treatment — at our Montvale, New Jersey, location. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan Kettering Bergen conducted 318 clinical trials. In the 10-year time frame, 318 clinical trials started and 10 clinical trials were completed, i.e. on average, 3.1% percent of trials that started reached the finish line to date. In the past 5 years, 193 clinical trials started and 10 clinical trials were completed. i.e. 5.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Bergen" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 251 trials, followed by "National Cancer Institute (NCI)" with 37 trials sponsored, "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "Pfizer" with 8 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Bergen" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Merck Sharp & Dohme LLC" with 15 trials as a collaborator, "Bristol-Myers Squibb" with 12 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator and "AstraZeneca" with 10 trials as a collaborator. Other collaborators include 226 different institutions and companies that were collaborators in the rest 148 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Bergen" are "Breast Cancer" (21 trials), "Multiple Myeloma" (17 trials), "Prostate Cancer" (16 trials), "Lung Cancer" (12 trials) and "Head and Neck Cancer" (10 trials). Many other conditions were trialed in "Memorial Sloan Kettering Bergen" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Bergen" are "Drug" (251 trials), "Radiation" (85 trials), "Other" (81 trials), "Procedure" (59 trials) and "Biological" (35 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (28 trials), "Nivolumab" (24 trials), "Quality-of-Life Assessment" (24 trials), "Questionnaire Administration" (20 trials) and "Computed Tomography" (19 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Bergen" are 277 trials for "All" genders, 45 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Bergen". undefined are not yet recruiting, 195 are recruiting, 120 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Memorial Sloan Kettering Bergen, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Bergen, 67 "Phase 1" clinical trials were conducted, 190 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".